Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: The utility of human fallopian tube mucosa as a novel source of multipotent stem cells for the treatment of autologous reproductive tract injury

Fig. 2

Flow cytometry analysis of cells harvested from human fallopian tube and human fallopian tube mucosa. Mesenchymal stem cells were positive for mesenchymal markers CD90, CD73, and CD105 and cell adhesion molecules CD166 and HLA-ABC and were negative for hematopoietic markers CD34, CD14, CD19, HLA-DR, and CD45. FMMSC, fallopian tube mucosa mesenchymal stem cell; FTMSC, fallopian tube mesenchymal stem cell

Back to article page